Jove
Visualize
Contact Us

Related Concept Videos

Anoxygenic Photosynthesis01:30

Anoxygenic Photosynthesis

Anoxygenic photosynthesis is a phototrophic process that captures light energy to drive carbon fixation without producing molecular oxygen. Unlike oxygenic photosynthesis, which utilizes water as an electron donor and releases oxygen, anoxygenic phototrophs use alternative electron donors such as hydrogen sulfide (H₂S), elemental sulfur (S⁰), or thiosulfate (S₂O₃²⁻). This process is carried out by diverse groups of bacteria, including purple bacteria, green sulfur bacteria, heliobacteria, and...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Anoxygenic Phototrophic Bacteria01:28

Anoxygenic Phototrophic Bacteria

Anoxygenic phototrophic bacteria are a diverse group of microorganisms that perform photosynthesis without producing oxygen. They primarily include purple sulfur bacteria, purple nonsulfur bacteria, green sulfur bacteria, and green nonsulfur bacteria. These bacteria are classified into the Gammaproteobacteria, Alphaproteobacteria, Betaproteobacteria, Chlorobi, and Chloroflexi lineages, each with distinct physiological and ecological adaptations.Purple sulfur bacteria belong to the...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative reverse vaccinology and computational modeling for the rational design of a broadly immunogenic multi-epitope vaccine against Marburg virus infection.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource.

Nature·2026
Same author

A Case of Posterior Reversible Encephalopathy Syndrome With Single-Agent Weekly Paclitaxel.

Cureus·2026
Same author

The Impact of Mitochondrial DNA Depletion on Mitochondrial Ultrastructure, Photosynthesis, and the mTERF Gene Family in <i>Chlamydomonas reinhardtii</i>.

International journal of molecular sciences·2026
Same author

Photocatalytic Degradation of Synozol Navy Blue Dye Using Ni-Ag Co-doped ZnO: Optimization, Mechanistic, Scavenging and Kinetics Studies.

Journal of fluorescence·2025
Same author

Automated Technique for Brain Tumor Detection From Magnetic Resonance Imaging Based on Local Features, Ensemble Classification, and YOLOv3.

BioMed research international·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tubercular fistula-in-ano.

Iram Bokhari1, Syed Sagheer Hussain Shah, Inamullah

  • 1Department of General Surgery, Jinnah Postgraduate Medical Centre, Karachi. i_bokhari@hotmail.com

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|September 2, 2008
PubMed
Summary

Tuberculosis is present in 11% of recurrent fistula-in-ano cases. Prompt diagnosis and anti-tuberculous treatment lead to successful healing within six months, preventing complications.

Related Experiment Videos

Area of Science:

  • Gastroenterology and Hepatology
  • Infectious Diseases
  • Surgical Infections

Background:

  • Recurrent fistula-in-ano poses a significant clinical challenge, often requiring extensive treatment.
  • Identifying underlying causes like tuberculosis is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence of tuberculosis in patients with recurrent fistula-in-ano.
  • To evaluate the efficacy of anti-tuberculous therapy in treating these cases.

Main Methods:

  • A case series of 100 patients with recurrent fistula-in-ano unresponsive to conventional surgery.
  • Exclusion of patients with comorbidities and evidence of other forms of tuberculosis.
  • Diagnostic procedures included fistulogram and histopathology of resected specimens.
  • Treatment involved anti-tuberculous therapy with a 6-month follow-up.

Main Results:

  • Biopsy-proven tuberculosis was identified in 11% of the studied patients (11 out of 100).
  • All diagnosed cases were male, with low-type, single, posterior fistulae.
  • Patients treated with anti-tuberculous therapy showed complete healing within 6 months without recurrence or anal stenosis.

Conclusions:

  • Tuberculosis should be considered in the differential diagnosis of recurrent fistula-in-ano to prevent treatment delays.
  • Anti-tuberculous therapy is highly effective, leading to successful fistula healing.